570 related articles for article (PubMed ID: 15105460)
1. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.
Chung KK; Thomas B; Li X; Pletnikova O; Troncoso JC; Marsh L; Dawson VL; Dawson TM
Science; 2004 May; 304(5675):1328-31. PubMed ID: 15105460
[TBL] [Abstract][Full Text] [Related]
2. Comment on "S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function".
Lipton SA; Nakamura T; Yao D; Shi ZQ; Uehara T; Gu Z
Science; 2005 Jun; 308(5730):1870; author reply 1870. PubMed ID: 15976289
[No Abstract] [Full Text] [Related]
3. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
Ko HS; Lee Y; Shin JH; Karuppagounder SS; Gadad BS; Koleske AJ; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16691-6. PubMed ID: 20823226
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
6. Parkin and defective ubiquitination in Parkinson's disease.
Dawson TM
J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
[TBL] [Abstract][Full Text] [Related]
7. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
[TBL] [Abstract][Full Text] [Related]
8. How do Parkin mutations result in neurodegeneration?
Imai Y; Takahashi R
Curr Opin Neurobiol; 2004 Jun; 14(3):384-9. PubMed ID: 15194120
[TBL] [Abstract][Full Text] [Related]
9. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin.
Im E; Yoo L; Hyun M; Shin WH; Chung KC
Open Biol; 2016 Aug; 6(8):. PubMed ID: 27534820
[TBL] [Abstract][Full Text] [Related]
10. NO parkin in Parkinson's disease.
Lancaster JR
Science; 2004 Jun; 304(5679):1905; author reply 1905. PubMed ID: 15218128
[No Abstract] [Full Text] [Related]
11. PICK1 inhibits the E3 ubiquitin ligase activity of Parkin and reduces its neuronal protective effect.
He J; Xia M; Yeung PKK; Li J; Li Z; Chung KK; Chung SK; Xia J
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7193-E7201. PubMed ID: 29987020
[TBL] [Abstract][Full Text] [Related]
12. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
[TBL] [Abstract][Full Text] [Related]
13. S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease.
Tsang AH; Lee YI; Ko HS; Savitt JM; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM; Chung KK
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4900-5. PubMed ID: 19273858
[TBL] [Abstract][Full Text] [Related]
14. Parkin: much more than a simple ubiquitin ligase.
Alves da Costa C; Checler F
Neurodegener Dis; 2012; 10(1-4):49-51. PubMed ID: 22204976
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.
Lo Bianco C; Schneider BL; Bauer M; Sajadi A; Brice A; Iwatsubo T; Aebischer P
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17510-5. PubMed ID: 15576511
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA
Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272
[TBL] [Abstract][Full Text] [Related]
18. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
[TBL] [Abstract][Full Text] [Related]
19. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.
Wang C; Ko HS; Thomas B; Tsang F; Chew KC; Tay SP; Ho MW; Lim TM; Soong TW; Pletnikova O; Troncoso J; Dawson VL; Dawson TM; Lim KL
Hum Mol Genet; 2005 Dec; 14(24):3885-97. PubMed ID: 16278233
[TBL] [Abstract][Full Text] [Related]
20. S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson's disease.
Sunico CR; Nakamura T; Rockenstein E; Mante M; Adame A; Chan SF; Newmeyer TF; Masliah E; Nakanishi N; Lipton SA
Mol Neurodegener; 2013 Aug; 8():29. PubMed ID: 23985028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]